1. Figueiredo, Thalita, Mendes, Ana P D, Moreira, Danielle P, Gage, Fred H, Zatz, Mayana. 2020. Inositol monophosphatase 1 (IMPA1) mutation in intellectual disability patients impairs neurogenesis but not gliogenesis. In Molecular psychiatry, 26, 3558-3571. doi:10.1038/s41380-020-00862-9. https://pubmed.ncbi.nlm.nih.gov/32839513/
2. Yang, Shao-Ying, Xie, Yi-Fan, Zhang, Tai-Mei, Zhang, Fang-Lin, Li, Da-Qiang. 2022. Inositol monophosphatase 1 (IMPA1) promotes triple-negative breast cancer progression through regulating mTOR pathway and EMT process. In Cancer medicine, 12, 1602-1615. doi:10.1002/cam4.4970. https://pubmed.ncbi.nlm.nih.gov/35796646/
3. Cryns, Kim, Shamir, Alon, Van Acker, Nathalie, Steckler, Thomas, Moechars, Dieder. 2007. IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity. In Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 33, 674-84. doi:. https://pubmed.ncbi.nlm.nih.gov/17460611/
4. Andreassi, Catia, Luisier, Raphaëlle, Crerar, Hamish, Saiardi, Adolfo, Riccio, Antonella. . Cytoplasmic cleavage of IMPA1 3' UTR is necessary for maintaining axon integrity. In Cell reports, 34, 108778. doi:10.1016/j.celrep.2021.108778. https://pubmed.ncbi.nlm.nih.gov/33626357/